Open AccessPreoperative Octreotide Treatment in Newly Diagnosed Acromegalic Patients with Macroadenomas Increases Cure Short-Term Postoperative Rates: A Prospective, Randomized Trial
Author(s) -
Sven M. Carlsen,
Morten LundJohansen,
Thomas Schreiner,
Sylvi Aanderud,
Øivind Johannesen,
Johan Svartberg,
John G. Cooper,
John Hald,
Stine Lyngvi Fougner,
Jens Bollerslev
Publication year - 2008
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2008-0315
Subject(s) - medicine , acromegaly , octreotide , transsphenoidal surgery , surgery , context (archaeology) , randomized controlled trial , pituitary adenoma , adenoma , somatostatin , growth hormone , hormone , paleontology , biology
Surgery is the primary treatment of acromegaly. However, it often fails to cure the patient. New strategies that improve surgical outcome are needed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom